Please use this identifier to cite or link to this item: https://open.uns.ac.rs/handle/123456789/14200
DC FieldValueLanguage
dc.contributor.authorAdami G.en
dc.contributor.authorSaag K.en
dc.contributor.authorChapurlat R.en
dc.contributor.authorGuañabens N.en
dc.contributor.authorHaugeberg G.en
dc.contributor.authorLems W.en
dc.contributor.authorMatijević, Radmilaen
dc.contributor.authorPeel N.en
dc.contributor.authorPoddubnyy D.en
dc.contributor.authorGeusens P.en
dc.date.accessioned2020-03-03T14:55:20Z-
dc.date.available2020-03-03T14:55:20Z-
dc.date.issued2019-01-01en
dc.identifier.issn1759720Xen
dc.identifier.urihttps://open.uns.ac.rs/handle/123456789/14200-
dc.description.abstract© The Author(s), 2019. Biologics are substances synthetized from biological sources used in the prevention and treatment of several diseases. Rheumatologists have many years of experience with biologics for the treatment of immune-mediated diseases and osteoporosis. Randomized clinical trials and postmarketing studies have demonstrated that treatment with biologics can result, albeit infrequently, in serious adverse events. To date, several risk mitigation strategies have been identified and implemented. The objective of the present perspective review is to examine the risk mitigation strategies of biologic treatments, with special focus on anti-tumor necrosis factors and denosumab.en
dc.relation.ispartofTherapeutic Advances in Musculoskeletal Diseaseen
dc.titleBalancing benefits and risks in the era of biologicsen
dc.typeOtheren
dc.identifier.doi10.1177/1759720X19883973en
dc.identifier.scopus2-s2.0-85074160007en
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85074160007en
dc.relation.volume11en
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptMedicinski fakultet, Katedra za medicinsku rehabilitaciju-
crisitem.author.parentorgMedicinski fakultet-
Appears in Collections:MDF Publikacije/Publications
Show simple item record

SCOPUSTM   
Citations

7
checked on Nov 20, 2023

Page view(s)

28
Last Week
7
Last month
0
checked on May 10, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.